Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

4.8K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
4.8K
Blood Pressure01:30

Blood Pressure

2.6K
Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
2.6K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

3.1K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.1K
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

3.4K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.4K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

609
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
609

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.

The Annals of pharmacotherapy·2026
Same author

Zoliflodacin for Urogenital Gonorrhea Infections.

The Annals of pharmacotherapy·2026
Same author

Recovery and Stability of Omadacycline 150-mg Crushed Tablets Dispersed in Food or Water and Administered via Nasogastric Tube.

Open forum infectious diseases·2026
Same author

Candidiasis epidemiology and outcomes including emergence of <i>Candida auris</i> from a large, Southern US metro area: a six-year evaluation.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2025
Same author

An Updated Review of Novel Triglyceride-Lowering Therapies in Adults with Familial Chylomicronemia Syndrome.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2025
Same author

A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile Risk.

The Journal of infectious diseases·2025

相关实验视频

Updated: Sep 11, 2025

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.4K

益生菌通过调节肠道微生物组合和功能来改善血压控制:系统性审查和元分析.

Abdulwhab Shremo Msdi1, Elisabeth M Wang1, Kevin W Garey1

  • 1Department of Pharmacy Practice and Translational Research, College of Pharmacy, University of Houston, 4349 Martin Luther King Boulevard, Houston, TX 77204, USA.

Nutrients
|August 14, 2025
PubMed
概括

食纤维 (DFs) 和益生菌可以通过改变肠道细菌和增加有益的短链脂肪酸 (SCFA) 来降低血压 (BP). 本次审查强调了它们通过肠道微生物群调节来管理高血压的潜力.

关键词:
人类健康 人类健康 人类健康这种高血压,高血压.微生物组是一个微生物组.益生菌 益生菌前生物短链脂肪酸 短链脂肪酸这是一种共生共生.

更多相关视频

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.7K
An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
14:54

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products

Published on: October 20, 2018

8.5K

相关实验视频

Last Updated: Sep 11, 2025

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.4K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.7K
An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
14:54

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products

Published on: October 20, 2018

8.5K

科学领域:

  • 微生物学 微生物学
  • 心血管健康 心血管健康
  • 营养科学 营养科学

背景情况:

  • 食纤维 (DFs) 与降低血压 (BP) 和心血管死亡率有关.
  • 对于DFs的抗高血压作用的机制尚未完全理解.
  • 肠道微生物群和短链脂肪酸 (SCFA) 生产是潜在的媒介.

研究的目的:

  • 系统地审查和元分析DF如何影响BP监管.
  • 评估肠道微生物组成和SCFA生产在BP调节中的作用.
  • 评估益生菌在治疗高血压方面的疗效.

主要方法:

  • 在MEDLINE和EMBASE的系统搜索 (2014年1月至2024年12月).
  • 包括对DFs/prebiotics,BP以及肠道微生物群/SCFA变化的干预研究.
  • 人类试验的随机效应元分析和动物研究的分析.

主要成果:

  • 在高血压队列中,益生菌干预显著降低了SBP (-8.5 mmHg) 和DBP (-5.2 mmHg).
  • 动物研究显示了一致的血压降低效应.
  • 益生菌增加了SCFA产生细菌 (例如Bifidobacteria) 和SCFA水平,调节免疫,血管和神经激素通路.

结论:

  • 益生菌补充剂对高血压患者的血压稳定有希望.
  • 益处很可能是由肠道微生物群调节和增强的SCFA产生的.
  • 准肠道微生物群是心血管健康的可行策略.